149 related articles for article (PubMed ID: 32110040)
1. In vitro Transport Ability of
Lian G; Yuan J; Gao Y
Onco Targets Ther; 2020; 13():1413-1419. PubMed ID: 32110040
[TBL] [Abstract][Full Text] [Related]
2. ABCC2 (1249G > A) polymorphism implicates altered transport activity for sorafenib.
Wei D; Zhang H; Peng R; Huang C; Bai R
Xenobiotica; 2017 Nov; 47(11):1008-1014. PubMed ID: 27855531
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.
Wen X; Joy MS; Aleksunes LM
Pharm Res; 2017 Aug; 34(8):1637-1647. PubMed ID: 28405913
[TBL] [Abstract][Full Text] [Related]
4. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
[TBL] [Abstract][Full Text] [Related]
5. Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.
Haenisch S; May K; Wegner D; Caliebe A; Cascorbi I; Siegmund W
Pharmacogenet Genomics; 2008 Apr; 18(4):357-65. PubMed ID: 18334920
[TBL] [Abstract][Full Text] [Related]
6. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy.
Kim WJ; Lee JH; Yi J; Cho YJ; Heo K; Lee SH; Kim SW; Kim MK; Kim KH; In Lee B; Lee MG
Pharmacogenet Genomics; 2010 Apr; 20(4):249-56. PubMed ID: 20216337
[TBL] [Abstract][Full Text] [Related]
7. Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular disposition.
Elens L; Tyteca D; Panin N; Courtoy P; Lison D; Demoulin JB; Haufroid V
Pharmacogenet Genomics; 2011 Dec; 21(12):884-93. PubMed ID: 22027652
[TBL] [Abstract][Full Text] [Related]
8. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
Shen XM; Cheng J
DNA Cell Biol; 2019 Mar; 38(3):250-255. PubMed ID: 30632789
[TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients' and donors' ABCC2 gene variants, and their interactions.
Božina N; Lalić Z; Nađ-Škegro S; Borić-Bilušić A; Božina T; Kaštelan Ž; Trkulja V
Eur J Clin Pharmacol; 2017 Sep; 73(9):1129-1140. PubMed ID: 28624888
[TBL] [Abstract][Full Text] [Related]
10.
Gao YL; He B
DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659
[TBL] [Abstract][Full Text] [Related]
11. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid.
Huisman MT; Chhatta AA; van Tellingen O; Beijnen JH; Schinkel AH
Int J Cancer; 2005 Sep; 116(5):824-9. PubMed ID: 15849751
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients.
Ogasawara K; Chitnis SD; Gohh RY; Christians U; Akhlaghi F
Clin Pharmacokinet; 2013 Sep; 52(9):751-62. PubMed ID: 23633119
[TBL] [Abstract][Full Text] [Related]
13. Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone.
Lagas JS; van der Kruijssen CM; van de Wetering K; Beijnen JH; Schinkel AH
Drug Metab Dispos; 2009 Jan; 37(1):129-36. PubMed ID: 18845662
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.
Werk AN; Bruckmueller H; Haenisch S; Cascorbi I
Pharmacogenet Genomics; 2014 Jun; 24(6):283-91. PubMed ID: 24743544
[TBL] [Abstract][Full Text] [Related]
15. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
Kuteykin-Teplyakov K; Luna-Tortós C; Ambroziak K; Löscher W
Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635
[TBL] [Abstract][Full Text] [Related]
16. Transport-metabolism interplay: LXRalpha-mediated induction of human ABC transporter ABCC2 (cMOAT/MRP2) in HepG2 cells.
Adachi T; Nakagawa H; Hagiya Y; Yasuoka T; Ishikawa T
Mol Pharm; 2009; 6(6):1678-88. PubMed ID: 19588995
[TBL] [Abstract][Full Text] [Related]
17. Influence of ABCB1 (1236C > T, 2677G > T and 3435C > T) polymorphisms on the transport ability of P-gp-mediated sunitinib in Caco-2 cell line.
Tan DQ
Xenobiotica; 2020 Mar; 50(3):346-353. PubMed ID: 31023123
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells.
Arlanov R; Porter A; Strand D; Brough R; Karpova D; Kerb R; Wojnowski L; Schwab M; Lang T
Hum Mutat; 2012 Apr; 33(4):750-62. PubMed ID: 22290738
[TBL] [Abstract][Full Text] [Related]
19. The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature.
Chen P; Yan Q; Xu H; Lu A; Zhao P
Genet Test Mol Biomarkers; 2014 Feb; 18(2):106-11. PubMed ID: 24325761
[TBL] [Abstract][Full Text] [Related]
20. Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs.
Peng R; Zhang H; Zhang Y; Wei DY
Xenobiotica; 2016 Oct; 46(10):948-52. PubMed ID: 26822676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
